Hiroshi Ogi

855 total citations
40 papers, 607 citations indexed

About

Hiroshi Ogi is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hiroshi Ogi has authored 40 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hiroshi Ogi's work include Cancer Immunotherapy and Biomarkers (7 papers), Effects and risks of endocrine disrupting chemicals (5 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Hiroshi Ogi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Effects and risks of endocrine disrupting chemicals (5 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Hiroshi Ogi collaborates with scholars based in Japan, United States and Germany. Hiroshi Ogi's co-authors include Kyoko Itoh, Shinji Fushiki, Takeshi Yaoi, Yasuhiro Fujiwara, Keiko Nakamura, Noboru Oda, Yuko Makita, Kenta Kajihara, Akemi Koshiba and Kazuaki Chayama and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Hiroshi Ogi

37 papers receiving 598 citations

Peers

Hiroshi Ogi
M. Goto Japan
Hiroshi Ogi
Citations per year, relative to Hiroshi Ogi Hiroshi Ogi (= 1×) peers M. Goto

Countries citing papers authored by Hiroshi Ogi

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Ogi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Ogi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Ogi more than expected).

Fields of papers citing papers by Hiroshi Ogi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Ogi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Ogi. The network helps show where Hiroshi Ogi may publish in the future.

Co-authorship network of co-authors of Hiroshi Ogi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Ogi. A scholar is included among the top collaborators of Hiroshi Ogi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Ogi. Hiroshi Ogi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugiyama, Yoichiro, Hiroshi Ogi, Aya Miyagawa‐Hayashino, et al.. (2025). Applications of Multiplex Immunohistochemistry in Evaluating Spatiotemporal Heterogeneity of T Cells. SHILAP Revista de lepidopterología. 5(1). 7–7. 1 indexed citations
2.
Ogi, Hiroshi, Shigeru Moriwaki, Satoru Yasukawa, et al.. (2025). Low density of intratumoral M1-macrophage infiltration may correlate with worse prognosis in low-grade early-stage uterine endometrioid carcinoma. Gynecologic Oncology Reports. 59. 101758–101758.
3.
Imura, Tetsuya, et al.. (2025). Activation of S1PR2 on macrophages and the hepatocyte S1PR2/RhoA/ROCK1/MLC2 pathway in vanishing bile duct syndrome. PLoS ONE. 20(1). e0317568–e0317568. 2 indexed citations
4.
Mukudai, Shigeyuki, Hiroshi Ogi, Eiichi Konishi, et al.. (2025). Neoadjuvant therapy-induced immune dynamics and myeloid-associated resistance in advanced head and neck cancer. npj Precision Oncology. 9(1). 167–167.
5.
Tsujikawa, Takahiro, Shigeyuki Mukudai, Hiroshi Ogi, et al.. (2024). Rapid multiplex immunohistochemistry for characterizing tumor-immune microenvironment. Heliyon. 10(13). e33830–e33830. 1 indexed citations
6.
Tsujikawa, Takahiro, Aya Miyagawa‐Hayashino, Shigeyuki Mukudai, et al.. (2024). Neutrophil‐to‐lymphocyte ratio associates with nutritional parameters, intratumoral immune profiles, and clinical outcomes of pembrolizumab in head and neck squamous cell carcinoma. Head & Neck. 46(8). 1956–1964. 6 indexed citations
7.
Fumino, Shigehisa, Mayumi Higashi, Hiroshi Ogi, et al.. (2024). The clinical impact of macrophage polarity after Kasai portoenterostomy in biliary atresia. Frontiers in Pediatrics. 12. 1338131–1338131. 4 indexed citations
8.
Ogi, Hiroshi, Kyoko Masuda, Satoru Okada, et al.. (2023). Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expression. Cancer Immunology Immunotherapy. 72(8). 2585–2596. 3 indexed citations
9.
Ishii, Hiroki, Takahiro Tsujikawa, Naoki Oishi, et al.. (2022). Genomic and immune microenvironment profiling in a case of metastatic intrathyroid thymic carcinoma. SHILAP Revista de lepidopterología. 10(7). e6050–e6050. 3 indexed citations
10.
Tsujikawa, Takahiro, Aya Miyagawa‐Hayashino, Akihito Arai, et al.. (2021). Spatially resolved immune microenvironmental profiling for follicular thyroid carcinoma with minimal capsular invasion. Modern Pathology. 35(6). 721–727. 10 indexed citations
11.
Tsujikawa, Takahiro, Hiroshi Ogi, Aya Miyagawa‐Hayashino, et al.. (2020). Prognostic significance of spatial immune profiles in human solid cancers. Cancer Science. 111(10). 3426–3434. 29 indexed citations
12.
Mikawa, Sumiko, et al.. (2020). Use of vertebral left atrial size for staging of dogs with myxomatous valve disease. Journal of Veterinary Cardiology. 30. 92–99. 21 indexed citations
14.
Sairaku, Akinori, et al.. (2018). Increased Urinary Liver-Type Fatty Acid–Binding Protein Level Predicts Worsening Renal Function in Patients With Acute Heart Failure. Journal of Cardiac Failure. 24(8). 520–524. 6 indexed citations
15.
Goto, Shoko, Hiroshi Ogi, Shinji Fushiki, & Kyoko Itoh. (2017). Prenatal and lactational bisphenol A exposure does not alter serotonergic neurons morphologically in the murine dorsal raphe nucleus. Brain and Development. 39(6). 475–482. 4 indexed citations
16.
Ogi, Hiroshi, Kyoko Itoh, Hiroshi Ikegaya, & Shinji Fushiki. (2015). Alterations of neurotransmitter norepinephrine and gamma-aminobutyric acid correlate with murine behavioral perturbations related to bisphenol A exposure. Brain and Development. 37(8). 739–746. 25 indexed citations
17.
Suenari, Kazuyoshi, Yukiko Nakano, Hiroshi Ogi, et al.. (2012). Left atrial thickness under the catheter ablation lines in patients with paroxysmal atrial fibrillation: insights from 64-slice multidetector computed tomography. Heart and Vessels. 28(3). 360–368. 53 indexed citations
18.
Nakano, Yukiko, Wataru Shimizu, Hiroshi Ogi, et al.. (2010). A spontaneous Type 1 electrocardiogram pattern in lead V2 is an independent predictor of ventricular fibrillation in Brugada syndrome. EP Europace. 12(3). 410–416. 9 indexed citations
19.
Yaoi, Takeshi, Kyoko Itoh, Keiko Nakamura, et al.. (2008). Genome-wide analysis of epigenomic alterations in fetal mouse forebrain after exposure to low doses of bisphenol A. Biochemical and Biophysical Research Communications. 376(3). 563–567. 163 indexed citations
20.
Yamamoto, Hideya, et al.. (2008). Disopyramide for transient high-degree atrioventricular block in a young patient with a history of syncope. Journal of Cardiology. 52(1). 59–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026